首页> 美国卫生研究院文献>American Journal of Physiology - Lung Cellular and Molecular Physiology >Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses
【2h】

Mutations flanking the carbohydrate binding site of surfactant protein D confer antiviral activity for pandemic influenza A viruses

机译:表面活性剂蛋白D的碳水化合物结合位点侧翼的突变赋予大流行性甲型流感病毒抗病毒活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We recently reported that a trimeric neck and carbohydrate recognition domain (NCRD) fragment of human surfactant protein D (SP-D), a host defense lectin, with combinatorial substitutions at the 325 and 343 positions (D325A+R343V) exhibits markedly increased antiviral activity for seasonal strains of influenza A virus (IAV). The NCRD binds to glycan-rich viral envelope proteins including hemagglutinin (HA). We now show that replacement of D325 with serine to create D325S+R343V provided equal or increased neutralizing activity compared with D325A+R343V. The activity of the double mutants was significantly greater than that of either single mutant (D325A/S or R343V). D325A+R343V and D325S+R343V also strongly inhibited HA activity, and markedly aggregated, the 1968 pandemic H3N2 strain, Aichi68. D325S+R343V significantly reduced viral loads and mortality of mice infected with Aichi68, whereas wild-type SP-D NCRD did not. The pandemic H1N1 strains of 1918 and 2009 have only one N-linked glycan side on the head region of the HA and are fully resistant to inhibition by native SP-D. Importantly, we now show that D325A+R343V and D325S+R343V inhibited Cal09 H1N1 and related strains, and reduced uptake of Cal09 by epithelial cells. Inhibition of Cal09 was mediated by the lectin activity of the NCRDs. All known human pandemic strains have at least one glycan attachment on the top or side of the HA head, and our results indicate that they may be susceptible to inhibition by modified host defense lectins.
机译:我们最近报道了人类表面活性剂蛋白D(SP-D)(宿主防御凝集素)的三聚体颈部和碳水化合物识别域(NCRD)片段,在325和343位(D325A + R343V)具有组合取代表现出明显的抗病毒活性用于季节性甲型流感病毒(IAV)。 NCRD与包括血凝素(HA)在内的富含聚糖的病毒包膜蛋白结合。我们现在显示,与D325A + R343V相比,用丝氨酸替代D325以创建D325S + R343V可以提供相同或增加的中和活性。双突变体的活性明显高于任何一个突变体(D325A / S或R343V)。 D325A + R343V和D325S + R343V也强烈抑制HA活性,并显着聚集于1968年的大流行H3N2菌株Aichi68。 D325S + R343V显着降低了感染Aichi68的小鼠的病毒载量和死亡率,而野生型SP-D NCRD却没有。 1918年和2009年的大流行H1N1毒株在HA头部只有一个N-连接的聚糖侧,并且完全抵抗天然SP-D的抑制作用。重要的是,我们现在显示D325A + R343V和D325S + R343V抑制Cal09 H1N1和相关菌株,并减少上皮细胞对Cal09的摄取。 Cal09的抑制作用是由NCRD的凝集素活性介导的。所有已知的人类大流行毒株在HA头的顶部或侧面均具有至少一个聚糖连接,我们的结果表明,它们可能容易受到修饰的宿主防御凝集素的抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号